thereishope66
@thereishope66
Followers
405
Following
12K
Media
43
Statuses
8K
To all scientists, doctors and families who are fighting blindness: thank you very much for your great task.
Barcelona
Joined October 2011
Imagine your vision slowly fading. For millions, this is reality. Early detection and routine eye exams are key. This #SaveYourVisionMonth, Ocugen is advancing innovation through our novel modifier gene therapies that addresses major blindness diseases. #EyeHealth #GeneTherapy
0
27
121
I vosaltres, en feu denúncia i pressioneu una mica @SEGREcom @LaVanguardia @diariARA @VilaWeb @eldiarioes @publico_es ? Ens ajuded a resoldre un tema tan greu @sindicdegreuges? #desequitat #injustícia
M’ajudes a fer gran la denúncia @PostureigLleida @postudelleida ? La gent de #Lleida és queda sola en l’atenció de l’ictus, la gent de Ponent no interessa ni a @salutcat ni a @icscat. @LoPaudePonts fas un tema i el cantes a @rac1 ? #desequitat #injustíciasocial
0
3
2
Hoy ha salido publicado nuestro artículo: “Suplementación neuroprotectora en las distrofias hereditarias de la retina”.
1
4
8
Un implante en el cerebro permite recuperar la visión a un hombre ciego por una lesión en el nervio óptico Noticia completa:
elpais.com
Científicos de la Universidad Miguel Hernández de Elche estimularon la corteza visual del invidente hasta que logró percibir la luz, movimientos y hasta letras grandes
0
1
4
FDA grants Orphan Drug Designation to OpCT-001 for retinitis pigmentosa. The investigational iPSC-derived cell therapy from Bayer/BlueRock is being studied in the phase 1/2a CLARICO trial for inherited photoreceptor diseases. 👉 Read more: https://t.co/tQKkf2fTg5
#Retina
0
2
3
Nanoscope secures US patent for MCO optogenetic tech platform https://t.co/LvPUUdVqxP
glance.eyesoneyecare.com
Long-term extension from phase 2b/3 RESTORE trial notes potential of MCO-010 as a one-time, gene-agnostic optogenetic therapy.
0
0
1
🧪 Nanoscope obtiene una nueva patente en EE. UU. para su tecnología de restauración visual. La empresa ya cuenta con patentes en Japón y Australia y avanza en ensayos clínicos para enfermedades retinianas. Más información en nuestra web 👁️
0
4
5
2025: Un año de avances esperanzadores en la investigación de enfermedades de la retina https://t.co/DOmEa5jZ8U
0
1
2
Stanford’s Artificial Retina Project is advancing next-generation vision restoration with a novel retinal implant. Led by Dr. E.J. Chichilnisky, this collaboration unites neurosurgery, neuroscience, ophthalmology, and more. Support the milestones ahead: https://t.co/vcbvYpyuqI.
1
6
6
Ocugen’s new @FrontiersIn publication shares how faster analytics, improved assays, and emerging tech like automation and AI can advance #AAV gene therapy manufacturing, supporting our novel modifier gene therapies for major blindness diseases. #AAV5 🔗 https://t.co/lpoxlxvpOq
1
33
117
Kiora is proud to join @GlobalGenes' RARE-X Vision Consortium as a founding member—collaborating to advance research and develop new therapies for rare ocular diseases. Learn more here: https://t.co/CcapdukxC3
#KioraPharmaceuticals #RAREX #GlobalGenes #VisionResearch
0
2
3
We are transforming how retinal diseases are treated. CSO shares with @DrugTargetRe how our modifier gene therapy platform and lead program #OCU400 use a gene-agnostic approach to support healthy photoreceptor function. Read: https://t.co/zD8IXBGjfh
#Biotech #Genetherapy
0
32
115
Thrilled to announce @MeiraGTx's strategic collaboration with @EliLillyandCo to advance genetic medicines in ophthalmology! Together, we intend to bring hope to patients with serious eye conditions. https://t.co/4WW7hrNtW3
#GeneTherapy #Ophthalmology
0
2
4
Optogenetics for advanced retinal disease: A mutation-agnostic gene therapy approach offers new possibilities for patients, especially those with inherited retinal diseases.
modernretina.com
A mutation-agnostic gene therapy approach offers new possibilities for patients, especially those with inherited retinal diseases.
0
6
5
Optogenética para enfermedades retinianas avanzadas: Un enfoque de terapia génica independiente de la mutación ofrece nuevas posibilidades para los pacientes, especialmente aquellos con enfermedades retinianas hereditarias.
Optogenetics for advanced retinal disease: A mutation-agnostic gene therapy approach offers new possibilities for patients, especially those with inherited retinal diseases.
0
2
3
Thank you to our View Point Partners for supporting vision health education. https://t.co/Eu3kkzYEAR
#visionloss #visioneducation
0
2
2
Celebrating National STEM/STEAM Day! At LambdaVision, innovation drives everything we do—from advancing space-based biomanufacturing to developing our artificial retina that could help restore sight. Here’s to the innovators shaping the future of science & discovery! #STEM
0
2
2
🔬 La Univ. de Fudan prueba fotorreceptores artificiales basados en nanocables de telurio🧬 en pacientes con retinosis pigmentaria. 💡 Resultados preclínicos prometedores y ensayo piloto activo (NCT05853107). Más info 👇 🌐 https://t.co/eDHkQdPEvW
#MáculaRetina #Visión 👁️ #Retina
1
4
6
El 23 de octubre de 2025 se celebrarán las XXVII JORNADAS DE INVESTIGACIÓN FUNDACIÓN LUCHA CONTRA LA CEGUERA. Descarga el programa aquí: https://t.co/1dzOc8OdPX Las jornadas se emitirán en directo en el canal de youtube a través de este enlace:
0
2
2
Optogenetics offers a mutation-agnostic and disease-agnostic approach for patients with advanced retinal disease, notes Kenneth C. Fan, MD, MBA. Read more: https://t.co/qjUrfP8H23
#RetinalPhysician #retinasurgery #IRD #genetherapy #optogenetics #clinicaltrials #Conexiant
2
2
4